BCLI - BrainStorm Cell Therapeutics Inc.BrainStorm Cell Therapeutics Inc. (OTCBB BCLI): develops NurOwn cell therapy products sourced from adult stem cells for treatment of neurodegenerative diseases. It primarily focuses on the utilization of patients’ own bone marrow stem cells to generate neuron-like cells that would provide a treatment for Parkinson's disease, as well as for multiple sclerosis and other neurodegenerative disorders. The company was incorporated in 2000 under the name Wizbang Technologies, Inc. and changed its name to Golden Hand Resources, Inc. in 2003. Further, the name was changed to Brainstorm Cell Therapeutics, Inc. in 2004. Brainstorm Cell Therapeutics is based in New York City.
Website: https://www.brainstorm-cell.com/home.html